Is LUCD or COCH more profitable?

Lucid Diagnostics has a net margin of -876.72% compared to Envoy Medical's net margin of -9,875.64%. Company Net Margins Return on Equity Return on Assets Lucid Diagnostics -876.72% N/A -116.26% Envoy Medical -9,875.64% N/A -177.92%

Which has better valuation and earnings, PDEX or COCH?

Pro-Dex has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $66.59M 2.94 $8.98M $3.62 16.97 Envoy Medical $234K 226.04 -$23.76M -$1.01 N/A

Is PDEX or COCH more profitable?

Pro-Dex has a net margin of 16.08% compared to Envoy Medical's net margin of -9,875.64%. Pro-Dex's return on equity of 22.78% beat Envoy Medical's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 16.08% 22.78% 14.30% Envoy Medical -9,875.64% N/A -177.92%

Do analysts recommend COCH or INGN?

Envoy Medical currently has a consensus price target of $2.25, indicating a potential upside of 227.03%. Given Envoy Medical's higher possible upside, equities analysts clearly believe Envoy Medical is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has higher earnings and valuation, COCH or INGN?

Inogen has higher revenue and earnings than Envoy Medical. Inogen is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envoy Medical $234K 226.04 -$23.76M -$1.01 N/A Inogen $348.67M 0.52 -$22.75M -$0.91 N/A

Is COCH or INGN more profitable?

Inogen has a net margin of -7.08% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Inogen's return on equity. Company Net Margins Return on Equity Return on Assets Envoy Medical -9,875.64% N/A -177.92% Inogen -7.08% -12.90% -8.27%

Envoy Medical (COCH) Competitors

$0.69 +0.02 (+2.59%)

As of 12:49 PM Eastern

Compare

COCH vs. VANI, KRMD, LUCD, PDEX, and INGN

Should you buy Envoy Medical stock or one of its competitors? MarketBeat compares Envoy Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envoy Medical include Vivani Medical (VANI), KORU Medical Systems (KRMD), Lucid Diagnostics (LUCD), Pro-Dex (PDEX), and Inogen (INGN).

How does Envoy Medical compare to Vivani Medical?

Envoy Medical (NASDAQ:COCH) and Vivani Medical (NASDAQ:VANI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

Envoy Medical has a beta of 1.88, suggesting that its stock price is 88% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market.

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 7.1% of Envoy Medical shares are held by company insiders. Comparatively, 53.3% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$234K	226.04	-$23.76M	-$1.01	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
Vivani Medical	N/A	-264.04%	-79.85%

Envoy Medical presently has a consensus target price of $2.25, suggesting a potential upside of 227.03%. Vivani Medical has a consensus target price of $3.75, suggesting a potential upside of 183.02%. Given Envoy Medical's higher possible upside, research analysts clearly believe Envoy Medical is more favorable than Vivani Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Envoy Medical's average media sentiment score of 0.00 equaled Vivani Medical'saverage media sentiment score.

Company	Overall Sentiment
Envoy Medical	Neutral
Vivani Medical	Neutral

Summary

Vivani Medical beats Envoy Medical on 7 of the 13 factors compared between the two stocks.

How does Envoy Medical compare to KORU Medical Systems?

Envoy Medical (NASDAQ:COCH) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

In the previous week, KORU Medical Systems had 3 more articles in the media than Envoy Medical. MarketBeat recorded 3 mentions for KORU Medical Systems and 0 mentions for Envoy Medical. KORU Medical Systems' average media sentiment score of 0.65 beat Envoy Medical's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
Envoy Medical	Neutral
KORU Medical Systems	Positive

Envoy Medical has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.41, meaning that its stock price is 59% less volatile than the broader market.

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 7.1% of Envoy Medical shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Envoy Medical currently has a consensus price target of $2.25, indicating a potential upside of 227.03%. KORU Medical Systems has a consensus price target of $7.25, indicating a potential upside of 69.39%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

KORU Medical Systems has a net margin of -5.27% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

KORU Medical Systems has higher revenue and earnings than Envoy Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$234K	226.04	-$23.76M	-$1.01	N/A
KORU Medical Systems	$43.26M	4.54	-$2.64M	-$0.05	N/A

Summary

KORU Medical Systems beats Envoy Medical on 11 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to Lucid Diagnostics?

Lucid Diagnostics (NASDAQ:LUCD) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

74.0% of Lucid Diagnostics shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 6.9% of Lucid Diagnostics shares are held by company insiders. Comparatively, 7.1% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Lucid Diagnostics has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.88, meaning that its share price is 88% more volatile than the broader market.

Envoy Medical has lower revenue, but higher earnings than Lucid Diagnostics. Lucid Diagnostics is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lucid Diagnostics	$4.71M	40.48	-$58.01M	-$0.47	N/A
Envoy Medical	$234K	226.04	-$23.76M	-$1.01	N/A

Lucid Diagnostics currently has a consensus target price of $4.19, suggesting a potential upside of 345.95%. Envoy Medical has a consensus target price of $2.25, suggesting a potential upside of 227.03%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, research analysts plainly believe Lucid Diagnostics is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lucid Diagnostics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Lucid Diagnostics has a net margin of -876.72% compared to Envoy Medical's net margin of -9,875.64%.

Company	Net Margins	Return on Equity	Return on Assets
Lucid Diagnostics	-876.72%	N/A	-116.26%
Envoy Medical	-9,875.64%	N/A	-177.92%

In the previous week, Lucid Diagnostics had 2 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Lucid Diagnostics and 0 mentions for Envoy Medical. Lucid Diagnostics' average media sentiment score of 0.45 beat Envoy Medical's score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Lucid Diagnostics	Neutral
Envoy Medical	Neutral

Summary

Lucid Diagnostics beats Envoy Medical on 10 of the 15 factors compared between the two stocks.

How does Envoy Medical compare to Pro-Dex?

Pro-Dex (NASDAQ:PDEX) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

Pro-Dex has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$66.59M	2.94	$8.98M	$3.62	16.97
Envoy Medical	$234K	226.04	-$23.76M	-$1.01	N/A

Pro-Dex has a net margin of 16.08% compared to Envoy Medical's net margin of -9,875.64%. Pro-Dex's return on equity of 22.78% beat Envoy Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	16.08%	22.78%	14.30%
Envoy Medical	-9,875.64%	N/A	-177.92%

Pro-Dex has a beta of 0.02, indicating that its stock price is 98% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market.

In the previous week, Pro-Dex's average media sentiment score of 0.00 equaled Envoy Medical'saverage media sentiment score.

Company	Overall Sentiment
Pro-Dex	Neutral
Envoy Medical	Neutral

15.3% of Pro-Dex shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 45.9% of Pro-Dex shares are held by company insiders. Comparatively, 7.1% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Pro-Dex currently has a consensus target price of $70.00, suggesting a potential upside of 13.92%. Envoy Medical has a consensus target price of $2.25, suggesting a potential upside of 227.03%. Given Envoy Medical's higher possible upside, analysts plainly believe Envoy Medical is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Pro-Dex beats Envoy Medical on 10 of the 13 factors compared between the two stocks.

How does Envoy Medical compare to Inogen?

Envoy Medical (NASDAQ:COCH) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.

Envoy Medical currently has a consensus price target of $2.25, indicating a potential upside of 227.03%. Given Envoy Medical's higher possible upside, equities analysts clearly believe Envoy Medical is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Inogen has higher revenue and earnings than Envoy Medical. Inogen is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$234K	226.04	-$23.76M	-$1.01	N/A
Inogen	$348.67M	0.52	-$22.75M	-$0.91	N/A

Envoy Medical has a beta of 1.88, suggesting that its share price is 88% more volatile than the broader market. Comparatively, Inogen has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market.

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 7.1% of Envoy Medical shares are owned by insiders. Comparatively, 2.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Inogen has a net margin of -7.08% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
Inogen	-7.08%	-12.90%	-8.27%

In the previous week, Inogen had 3 more articles in the media than Envoy Medical. MarketBeat recorded 3 mentions for Inogen and 0 mentions for Envoy Medical. Inogen's average media sentiment score of 0.45 beat Envoy Medical's score of 0.00 indicating that Inogen is being referred to more favorably in the news media.

Company	Overall Sentiment
Envoy Medical	Neutral
Inogen	Neutral

Summary

Inogen beats Envoy Medical on 10 of the 17 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COCH vs. The Competition

Export

Metric	Envoy Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$52.89M	$5.69B	$6.80B	$12.66B
Dividend Yield	N/A	1.79%	2.59%	10.03%
P/E Ratio	-0.68	23.68	282.16	25.05
Price / Sales	226.04	58.86	576.18	79.91
Price / Cash	N/A	32.53	28.60	46.71
Price / Book	-1.64	6.48	10.96	6.18
Net Income	-$23.76M	$151.15M	$3.49B	$347.61M
7 Day Performance	2.08%	2.99%	0.45%	0.71%
1 Month Performance	-8.51%	-1.58%	-4.26%	-3.75%
1 Year Performance	-52.39%	4.54%	63.09%	20.17%

Envoy Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COCH Envoy Medical	2.348 of 5 stars	$0.69 +2.6%	$2.25 +227.0%	-53.6%	$52.89M	$234K	N/A	34
VANI Vivani Medical	3.4836 of 5 stars	$1.27 -3.1%	$3.75 +195.3%	-3.8%	$110.04M	N/A	N/A	20
KRMD KORU Medical Systems	3.4415 of 5 stars	$4.07 +1.4%	$7.25 +78.4%	+18.1%	$187.62M	$41.13M	N/A	80	Positive News Upcoming Earnings
LUCD Lucid Diagnostics	3.4973 of 5 stars	$0.90 -1.1%	$4.19 +363.2%	-12.8%	$183.37M	$4.71M	N/A	70	Gap Up
PDEX Pro-Dex	2.1096 of 5 stars	$55.62 -1.3%	$70.00 +25.9%	+23.7%	$176.28M	$66.59M	15.27	140

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COCH) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envoy Medical (COCH) Competitors

COCH vs. VANI, KRMD, LUCD, PDEX, and INGN

How does Envoy Medical compare to Vivani Medical?

Summary

How does Envoy Medical compare to KORU Medical Systems?

Summary

How does Envoy Medical compare to Lucid Diagnostics?

Summary

How does Envoy Medical compare to Pro-Dex?

Summary

How does Envoy Medical compare to Inogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envoy Medical (COCH) Competitors

COCH vs. VANI, KRMD, LUCD, PDEX, and INGN

How does Envoy Medical compare to Vivani Medical?

Which has more volatility and risk, COCH or VANI?

Do insiders & institutionals have more ownership in COCH or VANI?

Which has preferable earnings and valuation, COCH or VANI?

Is COCH or VANI more profitable?

Do analysts rate COCH or VANI?

Does the media favor COCH or VANI?

Summary

How does Envoy Medical compare to KORU Medical Systems?

Does the media favor COCH or KRMD?

Which has more risk and volatility, COCH or KRMD?

Do insiders & institutionals have more ownership in COCH or KRMD?

Do analysts prefer COCH or KRMD?

Is COCH or KRMD more profitable?

Which has better valuation and earnings, COCH or KRMD?

Summary

How does Envoy Medical compare to Lucid Diagnostics?

Do institutionals and insiders hold more shares of LUCD or COCH?

Which has more risk & volatility, LUCD or COCH?

Which has better valuation & earnings, LUCD or COCH?

Do analysts recommend LUCD or COCH?

Is LUCD or COCH more profitable?

Does the media prefer LUCD or COCH?

Summary

How does Envoy Medical compare to Pro-Dex?

Which has better valuation and earnings, PDEX or COCH?

Is PDEX or COCH more profitable?

Which has more volatility and risk, PDEX or COCH?

Does the media prefer PDEX or COCH?

Do institutionals & insiders have more ownership in PDEX or COCH?

Do analysts rate PDEX or COCH?

Summary

How does Envoy Medical compare to Inogen?

Do analysts recommend COCH or INGN?

Which has higher earnings and valuation, COCH or INGN?

Which has more volatility & risk, COCH or INGN?

Do insiders and institutionals believe in COCH or INGN?

Is COCH or INGN more profitable?

Does the media favor COCH or INGN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools